Article
Novel Embryoid Body–Based Method to Derive Mesenchymal Stem Cells from Human Embryonic Stem Cells
7 Nov 2009
Abstract excerpt
Application of human embryonic stem cells (hESCs) to stem-cell therapy is not feasible because of the risk of tumorigenicity and rejection. In contrast, human mesenchymal stem cells (hMSCs) are free from the risk of tumorigenicity and also have immune privilege. However, hMSCs obtained from adults have infinite variety in terms of the biological characteristics and functionality. We report here a new derivation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
